Kit tampone rapido per Sars-CoV-2

Kit tampone rapido per Sars-CoV-2

Kit tampone rapido per Sars-CoV-2 - - Lepu Medical

Sars-CoV-2 rapid antigen test kit for self-testing. The product is intended for the qualitative detection of antigen against SARS-CoV-2 in clinical specimens (nasal swab).
Available: shipped in 24H

Single rapid swab to aid in the diagnosis of SARS-CoV-2 infection.

Useful for the prevention of COVID-19.


  • Non invasive

  • Simple to use

  • No prescription needed

  • Quick, results in 15 minutes

  • Stable, high precision

  • Economic

Instructions for Use

  1. Wash and dry your hands. Then take out the test card from the outer package.

  2. Place the test card flat on the table, remove the adhesive covering layer.

  3. Pull the swab out of the end of the stick.
    Note: Do not touch the swab head.
    Note: Sampling in both nasal passages is required.
    The nasal swab head should be fully inserted into the nasal cavity until resistance is felt (approximately 2-3 cm approximately) and gently rotated 5 times. When removed, the sample should be drawn in the same way in another nasal cavity to ensure sufficient sample collection.

  4. Insert the swab head into well A from the bottom of well B.

  5. Add 6 drops of the Sample Processing Solution to well A. Then rotate the swab 2 turns in each direction. Note: False negative results may occur if the Sample Swab is not turned before closing the Test Card.

  6. Fold the left side, fully join two sides, start timing.

  7. Wait for the purple-red line to appear. The test results should be read within 15-20 minutes.

  8. After testing, insert the Test Card, Swab, and Sample Processing Solution bottle into the outer carton and seal tightly. Dispose of the bag in the waste container according to local laws and regulations.

This product is a lateral flow rapid immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens from anterior nasal swabs collected from an individual aged 18 years or older or collected from an adult from an individual aged under the age of 18.

This test is intended for use in individuals with symptoms or other epidemiological reasons for suspecting a COVID-19 infection. This product is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection.

The clinical performance study of the SARS-CoV-2 Rapid Antigen Test was conducted in Germany. A total of 222 clinical samples were used to perform the test. Positive and negative samples were all confirmed by PCR. The diagnostic sensitivity and diagnostic specificity of the product were 95.9% (90.8-98.2%) and 100% (96.3-100.0%) respectively.